Device type · DBM
Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
DBM
Immunology
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control
- Product code
- DBM
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5090
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DBM
Latest FDA decisions
- EliA M2 Immunoassay510(k)
K181556 · Decided Jul 13, 2018 · 30 days after receipt
Device type: Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (DBM) · Laboratory Medicine & Pathology
K163525 · Decided Sep 5, 2017 · 264 days after receipt
Device type: Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (DBM) · Laboratory Medicine & Pathology
K163133 · Decided Aug 8, 2017 · 273 days after receipt
Device type: Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (DBM) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2428-2008 · Started Jul 29, 2008 · Posted by FDA Sep 19, 2008
Reason given: The Homogeneous Positive control was released with a titer of 1:256 rather than the titer value of 1:128 reported on the QC Report Label included with each test kit.
Cause as FDA categorized it: Employee error
Z-0673-05 · Started Apr 12, 2004 · Posted by FDA Apr 6, 2005
Reason given: The data reduction program written for a specific automated microtiter plate instrument (Bio-Tek ELx800 reader) was found to be faulty. This program is used to calculate the cut off values for Diastat Anti-Mitochondrial Antibody Kit. Program should include a borderline specification to indicate repeat testing is...
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.